Bsure Medical solutions enable safe and knowledgeable use of implants for both clinicians and implant users.
In 2022 Bsure launched a patented DNA test to predict the risk of dermal filler complications, on the Dutch, Spanish, English, Hungarian and Norwegian markets.
In July 2023 a new patent was filed for a DNA test to predict the risk of having serious health complications related to breast implants. This test is planned to be launched in the first quarter of 2024.
Further research will be carried out for predicting the risk of complications with other foreign body implants, starting in 2024.